anonymous
Guest
anonymous
Guest
Anyone read the warn notice? They have known since December 2015.
Anyone read the warn notice? They have known since December 2015.
The regulatory changes that began to affect the company's business model in 2014 were written into law in 2011!!!
2011!
The entire ACA was published for review in 2011, with a year by year phase in schedule.
Why didn't the people running this company look ahead to reimbursement changes 4 years ago and plan ahead??
Why did they keep their archaic, outdated and ultimately fatalistic business model going like nothing was going to change reimbursement, when all one would have to do is read up on and interpret the changes coming to the marketplace?
Instead, they pretended nothing was happening. Anyone who didn't buy into the company line was castigated and vilified by the toxic management team here, like the jackass down in Texas or the "VP of marketing".
Now we're all screwed! How does that taste? My family is in turmoil now because of these morons.
The regulatory changes that began to affect the company's business model in 2014 were written into law in 2011!!!
2011!
The entire ACA was published for review in 2011, with a year by year phase in schedule.
Why didn't the people running this company look ahead to reimbursement changes 4 years ago and plan ahead??
Why did they keep their archaic, outdated and ultimately fatalistic business model going like nothing was going to change reimbursement, when all one would have to do is read up on and interpret the changes coming to the marketplace?
Instead, they pretended nothing was happening. Anyone who didn't buy into the company line was castigated and vilified by the toxic management team here, like the jackass down in Texas or the "VP of marketing".
Now we're all screwed! How does that taste? My family is in turmoil now because of these morons.
Attachment to WARN Notification
Beginning in the middle of 2014, the medical laboratory industry began to experience a series of regulatory changes that affected the Company’s business model, causing both revenues and profitability to fall precipitously. By late 2014, the Company was no longer generating positive cash flow. In addition, starting in Q4 of 2014 the Company began a series of defaults under its credit agreement. As a result of this default and the subsequent credit agreement amendment negotiation, the Company sought and received additional capital from its primary owner, Behrman Capital. During 2015, the Company’s liquidity and financial performance continued to deteriorate, thus causing additional credit agreement defaults in subsequent quarters and requiring the Company to seek additional capital from Behrman. In late 2015, after Behrman had made a series of equity investments in the Company, Behrman determined that it was unable to continue providing funding without a significant restructuring of the Company’s debt obligations. The Company was aware that for Behrman and the lenders to agree on the timing, priority and amount of new capital, the Company’s business had to be stabilized and its balance sheet had to be restructured. As a result of these defaults, the Company hired a restructuring advisor in October 2015 and engaged with its lenders, Madison Capital Funding and Regions Bank, to seek a long-term debt and/or equity financing and restructuring solution. In December 2015, Madison agreed to provide new revolving credit loans to the Company under the terms of a forbearance agreement while longer term options were explored, including, at the insistence of the lenders, a potential sale of the Company. In and following December 2015, the Company delayed giving notice to employees, because it believed that doing so would have likely eroded the confidence of doctors, patients and employees and in turn would have precluded the Company from raising additional debt and/or equity financing. Financing discussions with Behrman and the lenders continued (and term sheets were exchanged) until February 23, 2016, at which point Madison notified the Company that it was in default of the forbearance agreement and that Madison was no longer willing to support the Company (which included draws on the balance of the existing revolver) without the cooperation of Regions Bank, which had steadfastly refused to provide any financial support. Because the Company was nearly out of cash, and its prospects for obtaining new capital were unexpectedly withdrawn by Madison, the Company had no options other than to give notice of termination to its employees, make its final payroll, and cease operations.
. Dude. This was written by Sr Mgmt to avoid being sued. I'm sure it's not 100% accurate. While the law may have passed 2011, it doesn't impact diagnostic labs until this year when they have to report overall average reimbursement per CPT code. ACA is not the cause here. It sux. But don't forget the company had 60m of revenue coming in the door and is suddenly bankrupt, yet this was prepared in December...hmmmm. The investor made a lot of money in 2013, and they didn't want to reinvest in this teams plan. Simple. Sorry. It sux.The regulatory changes that began to affect the company's business model in 2014 were written into law in 2011!!!
2011!
The entire ACA was published for review in 2011, with a year by year phase in schedule.
Why didn't the people running this company look ahead to reimbursement changes 4 years ago and plan ahead??
Why did they keep their archaic, outdated and ultimately fatalistic business model going like nothing was going to change reimbursement, when all one would have to do is read up on and interpret the changes coming to the marketplace?
Instead, they pretended nothing was happening. Anyone who didn't buy into the company line was castigated and vilified by the toxic management team here, like the jackass down in Texas or the "VP of marketing".
Now we're all screwed! How does that taste? My family is in turmoil now because of these morons.
. Dude. This was written by Sr Mgmt to avoid being sued. I'm sure it's not 100% accurate. While the law may have passed 2011, it doesn't impact diagnostic labs until this year when they have to report overall average reimbursement per CPT code. ACA is not the cause here. It sux. But don't forget the company had 60m of revenue coming in the door and is suddenly bankrupt, yet this was prepared in December...hmmmm. The investor made a lot of money in 2013, and they didn't want to reinvest in this teams plan. Simple. Sorry. It sux.
if you are able still get into your company email it was posted thereWhere was this notice posted??